Label Uptake in Maternal and Fetal A/jax Mouse Tissues After Maternal Injections of Tritiated Cortisol: A Liquid Scintillation Study by Dodds, Gilbert E.
Loyola University Chicago
Loyola eCommons
Master's Theses Theses and Dissertations
1971
Label Uptake in Maternal and Fetal A/jax Mouse
Tissues After Maternal Injections of Tritiated
Cortisol: A Liquid Scintillation Study
Gilbert E. Dodds
Loyola University Chicago
This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in
Master's Theses by an authorized administrator of Loyola eCommons. For more information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1971 Gilbert E. Dodds
Recommended Citation
Dodds, Gilbert E., "Label Uptake in Maternal and Fetal A/jax Mouse Tissues After Maternal Injections of Tritiated Cortisol: A Liquid
Scintillation Study" (1971). Master's Theses. Paper 2541.
http://ecommons.luc.edu/luc_theses/2541
----------------,~---·----------------------~~--"'-------~--------------------·~ 
LABEL UPTAKE IN MATERNAL AND FETAL A/JAX 
MOUSE TISSUES AFTER MATERNAL INJECTIONS 
OF TRITIATED CORTISOL: A LIQUID 
SCINTILLATION STUDY 
BY 
GILBERT E. DODDS 
A Thesis Submitted to the Faculty of the Graduate School 
of Loyola University in Partial Fulfillment 
of the Requirements for the Degree of 
Master of Science 
JUNE 
1971 
Ubrary- ·Loyola University Medical Center 
AUTOBIOGRAPHY 
Gilbert E. Dodds was born in Detroit, Michigan on August 9, 1940. 
His boyhood years were spent at Perth, Ontario, Canada, where he 
graduated from the Perth Collegiate Institute in June, 1959. 
In September of the same year he enrolled at the University of 
Toronto in the Faculty of Engineering. A year later he transferred 
to the Faculty of Dentistry at the same institution where he received 
the degree of Doctor of Dental Surgery in 1965. 
In September, 1969, he entered the Graduate School of Loyola 
University in Chicago, Illinois. 
AC KN OWL EDGM ENTS 
May I take this opportunity to express a very special gratitude 
to al I those who have made this thesis possible. 
To Dr. Donald C. Hilgers and Dr. Gustav W. Rapp for giving me the 
opportunity to pursue graduate studies. 
To Dr. Walter E. Kisiel iski for all his time and energy and the 
use of his facilities at Argonne National Laboratory and especially 
for the privilege of knowing a truly great scientist. 
To Dr. Douglas C. Bowman for his patient assistance with the 
statistical analysis. 
To Dr. Norman K. Wood, my thesis advisor and personal friend, for 
his never failing desire to help and guide; a constant source of 
encouragement. 
To Mrs. Carole Wood for her meticulous typing. 
To my wife Barbara Aileen for her constant encouragement. 
CHAPTER 
1. 
2. 
3, 
4. 
5, 
6. 
7. 
8. 
TABLE OF CONTENTS 
PAGE 
INTRODUCTION AND STATEMENT OF THE PROBLEM ..... . 
REVIEW JF THE LITERATURE ...................... . 4 
A. METABOLISM OF CORTISOL..................... 4 
B. CORTISONE EXPERIMENTS ON FETAL AND 
IMMATURE TISSUE............................ 6 
C. CORTISONE-INDUCED CLEFT PALATE............. 7 
D. USE OF CORTISONE ISOTOPES IN PREGNANT 
MICE....................................... 8 
E. PREPARATION OF TISSUES FOR COUNTING........ 14 
F. OXIDATION METHODS FOR RECOVERY OF LABEL.... 14 
MATERIALS AND METHODS ......................... . 
FINDINGS ...................................... . 
DISCUSSION .................................... . 
SUMMARY AND CONCLUSIONS ................•....... 
BIBLIOGRAPHY .................................. . 
APPENDIX .........•............................. 
17 
21 
32 
38 
40 
43 
CHAPTER 1 
INTRODUCTION AND STATEMENT OF THE PROBLEM 
When the separation between the oral and nasal cavities formed by 
the secondary palate is incomplete after the period of normal closure, 
a condition knrn"n as cleft palate results. It is one of the most common 
congenital malformations found in man, occurring in about one out of 
every eight hundred live births according to Grace (1943). In untreated 
cases severe handicaps develop. Speech, mastication, deglutition and 
respiration are affected and as a result psychologic problems develop. 
In 1940, Warkany and Nelson showed that nutritional disturbances 
were contributing factors to cleft palate production. Fogh-Andersen 
(1942) demonstrated that genetic factors were also important. Strean 
and Peer (1956) thought that physiologic, emotional or traumatic stress 
played a role in human clefts by stimulating the adrenal cortex to 
secrete hydrocortisone. This correlates with the work of Baxter and 
Fraser (1950), Fraser and Fains tat (1951), and Kai ter (1957) who were 
able to produce clefts in mice before birth by giving cortisone to 
pregnant A/jax mice. 
Before 1967, most investigators assumed that the cleft palate 
producing action of cortisone was directly on the palatal shelf tissue 
and so almost all investigators dealt with changes in the fetal shelves. 
No one had attempted to determine whether cortisone injected into a 
-------------------------------- -
pregnant A/jax mouse actually arrived at the palatal shelves in 
sufficient quantities to influence their development. 
In 1967, Nasjleti, Avery, Spencer and Walden injected tritiated 
cortisone and using autoradiography were unable to detect label in the 
palatal tissues of the embryos, although, they did find it in the blood 
channels of the fetal 1 iver and heart. Marks (1969) and Schmitz (1970), 
however, were able to show conclusively that label did in fact reach 
the palatal shelves of the fetus after maternal injections of tritiated 
cortisol. 
The presence of label in the fetal tissues cannot be taken as 
proof of the presence of cortisol. Biochemical analysis must be done 
on the labeled material to determine what percentage of it is cortisol, 
cortisone metabolites, enol ization compounds or free tritium. 
The purpose of this investigation is as follows: 
1. a. To determine quantitatively the relative distribution 
of the label in various maternal and fetal tissues, 
such as liver, heart, kidney, spleen, brain, adrenals, 
maxilla and placenta, one hour post injection. 
b. To determine if there is a significant difference in 
the uptake of label by the various maternal tissues. 
---------------------------------------------------------------------------··1 
c. To determine if there is a significant difference in 
the uptake of label by the various fetal tissues. 
d. To determine if there is a significant difference 
between the label in the maternal and fetal tis~ues, 
i.e., is there free exchange of label across the 
placenta in A/jax mice. 
2. To determine the effect of a loading dose of cortisol on 
the degree of labeling recovered from the maternal and 
fetal tissues. 
3. To determine if there is a significant difference in labeling 
between placentas from the right uterine horn and placentas 
from the left uterine horn. 
4. To establish parameters for future chromatographic studies. 
CHAPTER 2 
REVIEW OF THE LITERATURE 
A. Metabolism of Cortisol (Harper, 1967) 
Steroid derivatives have the characteristic cyclopentanoper-
hydrophenanthrene nucleus. Those found in the adrenal cortex 
include compound E (cortisone), compound F (hydrocortisone or 
cortisol), 17 hydroxycorticosterone and aldosterone. 
They effect the metabolism of electrolytes, protein, carbo-
hydrates and fat. They influence basic physiologic processes 
such as cell permeability and the synthesis of RNA and protein. 
Cor.tisol (compound F) is the major free circulating adreno-
cortical hormone in the plasma. 
Renin secreted by the juxtaglomerular cells of the kidney and 
activated through the intermecliary angiotensin stimulates the 
adrenal cortex and produces aldosterone. 
Aldosterone is the principal mineralocorticoid and is important 
in the regulation of serum electrolytes. It increases the resorp-
tion of sodium and chloride by the renal tubules and decreases 
their excretion by sweat glands, and gastrointestinal tract. 
L 
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The C-21 corticosteroids, examples of which are 17-hydroxy -
11-dehydrocortisone (compound E or cortisone) and 17-hydroxycorti-
costerone (compound For hydrocortisone or cortisol), produce a 
number of metabolic effects. They elevate blood glucose, decrease 
carbohydrate oxidation, increase glycogen synthesis, decrease 
hepatic 1 ipogenesis from carbohydrate, increase gluconeogenesis 
and increase protein catabolism. They cause involution of the 
thymus, eosinopenia, lymphopenia, leukocytosis and erythremia. 
The effects of glucocorticoids are thought to be mediated through 
RNA synthesis of enzymes. 
About one-half of the corticosteroids in the blood are bound 
loosely to serum proteins. As they pass through the liver the 
steroids are inactivated and conjugated with glucuronic acid. Both 
free and conjugated corticosteroid are excreted with the bile into 
the intestine and may then be reabsorbed by the enterohepatic 
circulation. Excretion of conjugated corticosteroids takes place 
in the kidney. 
While most steroids in the blood are loosly bound to serum 
proteins, their conjugates are not and have a greater aqueous solu-
bility. This wil 1 account for the rapid excretion of conjugates 
by the kidney while the unconjugated material remains in the serum. 
B. Cortisone Experiments on Fetal and Immature Tissue 
Evans (1953) injected cortisone into the chorioallantoic 
membrane of chick embryos at 8 days of incubation and sacrificed 
at daily intervals from 10 through 18 days incubation. He found 
that the entire embryo showed growth inhibition. Peak inhibition 
was observed betwePn 8 and 10 days. 
Buno and Goyena (1955) removed the femurs from chick embryos 
at 7 days incubation. One they cultivated in a medium containing 
cortisone and the other, a control, was placed in a cortisone-free 
medium. They found that the anlages cultivated in the media 
containing cortisone were inhibited in their growth, but when they 
were removed and placed in a non-cortisone media they grew rapidly 
and made up for the retardation. Histologically there was no 
cellular atrophy or reduction in the intercellular substance of 
the cartilage. The action appeared to be a direct inhibition of 
cell proliferation. 
Ragan et al (1949) produced wounds on the ears of rabbits. 
One group was used as a control group while the others were treated 
with cortisone I .M. The treated animals showed delayed production 
of granulation tissue, and there was a striking depression of new 
growth of all the elements of connective tissue. 
r 
Layton (1951) found that cortisone inhibited the uptake of 
labeled sulfate by embryonic chick heart and skeletal muscle in 
vitro. He also found a similar inhibition in tissue of healing 
wounds. Previously he had shown that wound granulation tissue 
had a high capacity for incorporating inorganic sulfate in the 
formation of chondroitin sulfate. Th~s, he concluded that the 
cortisone inhibited the synthesis of chondroitin sulfate in con-
nective tissue. 
Mott (1968) administered cortisone to pregnant mice to induce 
cleft palates in the offspring. Then one hour before sacrifice he 
injected tritiated thymidine to label the cells as they prepared 
to undergo mitosis. His results indicated a decrease in mitosis 
in mesenchymal tissue of the palatal shelves of the cortisone-
treated group and also a decrease in amount of intercellular sub-
stance, which he hypothesized was due to a concomitant decrease 
in the acid mucopolysaccharide content of the intercellular 
substance. 
C. Cortisone-Induced Cleft Palate 
Many cleft palate induction studies have been done with 
cortisol and cortisone. Marks (1969) and Scbmitz (1970) reviewed 
this phase of the literature. 
D. Use of Cortisone Isotopes in Pregnant Mice 
Hanngren, Hansson, Sjostrand and Ullberg (1964) used 14c-corti-
d 14c · 1 · · d 1 • · f d sane an -cort1so lnJecte intravenous y into mice o an unname 
strain. Each animal was given 0. 14 mg. of cortisone (10 uCi) or 
0.07 mg. of cortisol (5 uCi) and was sacrificed at intervals varying 
from 5 minutes to 24 hours after the injection. 
Wholebody autoradiography (freeze-dried sections were placed 
on X-ray film) indicated no significant differences 20 minutes 
after injection between the two drugs. Label appeared in all the 
· f b h 14c · 1 d 14c · · · d · 1 tissues o ot -cort1so an -cortisone 1nJecte an1ma s. 
Throughout the observation time, radioactivity was lower in most 
organs than in the blood, but in maternal liver, kidney and sali-
vary and lacrimal glands the uptake rapidly became greater than in 
the blood, reaching a peak 20 minutes after injection. Thereafter 
the highest concentrations were in the maternal liver, kidney and 
intestinal contents. The central nervous system showed very I ittle 
uptake. However, after five minutes there was fairly high 
pituitary radioactivity. The placentas showed more activity than 
the blood. There was fairly even distribution throughout the 
fetuses, but the adrenal cortex, gastric mucosa and cerebrospinal 
fluid showed heavier labeling than the other tissues. The period 
of gestation was not given. 
Chromatograms from maternal liver, intestine and kidney, 20 
minutes after injection, indicated that the label was associated 
with unidentified metabolites, except in the case of urine where 
cortisone was present also. 
According to the author, the penetration through the placenta 
was relatively poor. The autoradiographic technique used in the 
work was not sensitive enough to yield meaningful data. 
Nasjle;:i, Avery, Spencer and Walden (1967) used tritium labeled 
cortisol and A/jax mice at 121 days gestation. They injected 10 mg. 
of cortisol with a specific activity of 50 uCi mg. or 500 uCi per 
mouse intramuscularly. Blood samples were taken from the choroid 
plexus in heparinized capillary tubes at intervals ranging from 
30 minutes to 6i days after injection. Fluorometric and chromato-
graphic studies were then done on the plasma to determine whether 
the label was associated with cortisone or recirculating metabolites. 
At various time after injection the animals were sacrificed, embryos 
were studied autoradiographically, and the maternal livers, adrenals, 
spleens, kidneys and thymus glands were counted in a Packard liquid 
scintillation counter. Samples for scintillation counting were 
prepared as described by Frenkel, Whalley, Knorpp and Korst (1962). 
A thixotropic gelling agent was used to suspend the products of 
rapid hydrolysis of the tissue in the toluene-dioxane-ethanol 
scintillator. They reported that radioactivity in plasma reached 
a peak 40 minutes after injection and chromatography indicated 
that 72% was associated with cortisone. They also reported that 
at that time all the tissues investigated showed a concentration 
of tritium e~ual to or in excess of that found in plasma at 40 
minutes. 
Hanngren et al (1964) found a high uptake in the maternal 
adrenal cortex five minutes after injection (species of mouse not 
identified), but twenty minutes later the adrenal medulla showed 
more label and very little label was left in the cortex. Nasjleti 
et al reported a more delayed uptake in the adrenal (A/jax mice) 
reaching a peak at two hours in contrast to the more rapid uptake 
in the other organs. However, they did not differentiate between 
cortex and medulla. Autoradiographic preparations of the embryos 
showed label in the blood channels of the liver and heart. 
According to the author this activity appeared 5~ hours after 
radioactive injection. The author feels that it may be free 
tritium or a metabolite of cortisone or tritiated cortisone. He 
also states without proof or reference, that 11 the transport and 
transfer of hormones between mother and fetus involves complex 
physiologic and biochemical interactions. 11 
In 1969, Marks, working with A/jax mice on the twelfth day of 
pregnancy and using autoradiographic techniques, was able to 
demonstrate a significant amount of label in the fetal palatal 
shelves as well as the placentas. He, unlike Nasjleti et al, and 
Hanngren et al administered a 11 Joading dose" of 2.5 mg. of 11 cold 11 
cortisone acetate 30 minutes before the tritiated cortisol. Both 
injections were made intramuscularly in the left and right hamstring 
muscles respectively. He expected the first injection of unlabeled 
cortisone to overload the metabolic processes responsible for the 
breakdown and elimination of the drug. Then the labeled cortisol 
would be allovJed to circulate undestroyed for a longer period of 
time and its chances of being found in the fetal tissues would be 
enhanced. Marks used the same amount of label as Nasjleti et al 
(500 uCi) on two mice and only 50 uCi on the remainder, but the 
dosage of cortisol was much lower. Animals were sacrificed five 
hours after the label was injected. This was the time reported by 
Nasjleti at which label appeared in the fetuses, although, both 
Hanngren and Nasjleti reported peak concentrations in the maternal 
tissues within 20 to 40 minutes. 
Schmitz (1970), studying Marks specimens, reported a direct 
correlation between the amount of label in the fetal palatal pro-
cesses and the amount in the placenta. Also he noted'significant 
differences between placentas and fetal tissues obtained from 
different mothers. 11 Marks and Schmitz both reported a higher 
level of activity in placentas and fetuses taken from the left 
side of the uterus than in those from the right side. This they 
attributed to possibly a better circulation on the left side but 
did not show that such was the case. 
In 1968, Levine, Yaffe and Back compared the uptake in fetal 
tissues of A/jax and CBA strain mice. On the 11th day of gestation 
14
c-A-ring labeled cortisol together with 2.5 mg. of "cold'' carrier 
was injected subcutaneously. Animals were sacrificed at intervals 
of 30, 60, 120 and 240 minutes after the injection. Fetuses were 
individually macerated in Vortis homogenizer and counted in a 
liquid scintillator using dioxane, 1 iquoflur and toluene as the 
suspension medium. The authors reported that in each case the 
A/jax strain showed a much higher fetal uptake than the CBA strain 
and that the biologic half-life of the labeled cortisol in the 
A/jax fetuses was about twice what it was in the CBA fetuses. 
However, the data compared was in percentage of injected dose and 
the two groups did not receive equal doses so this invalidates the 
conclusions. 
By extrapolation of the graph showing the percent of the 
injected dose taken up by each of the two strains of fetuses at 
the various time intervals studied, it would appear that initially 
the uptakes were similar. It should be noted here though, that 
extrapolation in this case was not val id. Levine suggested that 
this similarity in uptake is due to similarities in the placental 
transport mechanism of the two strains. This he feels could be 
''anticipated in view of the rather permissive nature of placental 
transport which allows the overwhelming majority of drugs with low 
molecular weights to pass from mother to fetus." He suggested that 
the difference in susceptibility of the two strains is not due to 
differences in the placentas but rather to differences in metab-
olism and/or binding by the fetuses. 
Zarrow, Philpott and Denenberg (1970) working with pregnant 
Purdue-Wistar rats at day 21 of gestation and injecting 10 uCi of 
14c 4 . . I . • 1 . 
- -cort1costerone intravenous y, reported s1m1 ar concentrations 
of label in maternal and fetal muscle, brain and hypothalmus 30 
minutes after injection. They concluded that there is ''free exchange 
across the placenta" but did not do chromatographic tests so have no 
proof that the corticosterone had not been metabolized. They cited 
the study done by Hanngren et al as additional proof of this free 
exchange, but Hannegren et al reported lower levels of activity in 
the fetuses than in the dams. Zarrow et al prepared their tissues 
as described in a previous article by Zarrow, Philpott, Dennenberg 
and O'Connor (1968). A 3:1 mixture of hydroxide of hyamine and 
30% aqueous sodium hydroxide was used to dissolve the tissue. 
The hydrogen peroxide was added for bleaching. 10 ml. of XDC 
scintillation fluid was used and the samples were counted in a 
r 
Packard Tri-Carb scintillation spectrometer. It is interesting to 
note that this previous experiment with two-day old rats showed a 
peak uptake in the tissues examined at about 30 minutes post 
injection. In this case 14c labeled corticosterone was also used 
and was given intraperitoneally. 
E. Preparation of Tissues for Counting 
Certain problems are inherent in the use of tritium in liquid 
scintillation procedures. Tritium being one of the least energetic 
nuclides is extremely sensitive to all quenching factors in liquid 
scintillation counting procedures. Solubilization, suspension and 
emulsification procedures have been routinely utilized but a high 
phosphorescence and chemiluminescence may produce a high background. 
In addition, chemical quenching, color quenching and light absorp-
tion by particles in th~ counting (scintillation) solution may 
increase the variance of the background, thus decreasing the 
sensitivity of the method. Also, oxygen in the solvent of liquid 
scintillation preparations exerts a quenching effect and has been 
described by Pringle et al (1953). Mahin (1966) described procedures 
for removing the oxygen by freezing the scintillation fluid in 1 iquid 
nitrogen and capping it when all the gas was expelled. 
F. Oxidation Methods for Recovery of Label 
By oxidizing the specimen the organic material is converted 
into carbon dioxide and water and the amount of activity in the 
specimen can be counted in a solvent suitable for counting water. 
Since the water resulting from combustion of dry biological sample 
is about 60% of the sample weight, it is possible to take the water 
of combustion of dry tissue representing about 4-5 gm. of fresh 
tissue and add this to a scintillating solution capable of holding 
only 4% water. Thus scintillating systems of low water holding 
capacity can be used, these are the most efficient cocktails. With 
this technique color quenching is avoided and the only chemical 
quenching comes from the water which is easily reproducible using 
blank scintillation fluid so that corrections for it can be made 
accurately. 
Many oxidation methods for preparing tritium samples have been 
used. Kelly et al (1961) placed dry tritium samples in a platinum 
basket in an oxygen filled flask and ignited the material by 
passing an electric current through the platinum basket by means 
of a transformer and platinum leads. After combustion the flask 
was placed on dry ice - chloroform - carbon tetrachloride bath so 
that the water vapor would condense and freeze. To dissolve the 
ice 20 ml. of toluene-phosphor solution containing 20% ethanol was 
added to the flask. A 15 ml. al iquote was then used for liquid 
scinti 1 lat ion counting. 
As already stated, oxygen is a severe quenching agent unless 
removed. Dobbs (1963) reported flushing the liquid scintillation 
with nitrogen to remove the oxygen that dissolves in it when in 
the combustion flask. He found that by doing this he could get a 
more constant and reproducible level of counting efficiency than 
when the nitrogen purge was omitted. He also showed that the loss 
of counts due to removal of tritiated water and methanol from the 
1 iquid scintillator by the nitrogen stream was negligible. 
Peets et al (1960) developed a method for the combustion of 
large samples. They used a continuous flow of oxygen into the 
flask during combustion and collected the water in a glass trap 
immersed in dry ice - chloroform - carbon tetrachloride. A back-
ground b.uildup or "memory effect'' 1-Jas a problem with this system 
after it had been operating for a time. This was due to retention 
of reversibly bound tritium by the glass surface of the apparatus. 
They found that this "memory effect" did not lower the recovery of 
tritium significantly, but it did result in high blank values and 
cross contamination of samples. They also found that this "bound" 
tritium could be removed by purging the tubes with steam. 
CHAPTER 3 
MATERIALS AND METHODS 
A. Mice 
A/jax mice were used in this study because they are so 
susceptible to cortisone-produced clefts and because most studies 
of cortisone-induced cleft palates have been done on this strain. 
A total of 30 females and 12 males eight weeks old were obtained 
from Jackson Laboratory in Bar Harbor, Maine. 
B. Feeding and Environment 
A special room in the animal quarters was used where the 
temperature and humidity were kept constant and the lights were 
automatically regulated to turn off at 6 p.m. and on at 8 a.m. 
Standard Purina rat chow and tap water were given ad 1 ibitum. 
C. Mating 
The males were isolated, each in a separate cage for five to 
six days and then one female was placed in each cage with a male. 
Checks for vaginal copulation plugs were made at 8:30 a.m. and 
5 p.m. for the next five days. Females with plugs were isolated 
in separate cages. The day on which the plug was found was 
recorded as day zero. The date and weight were recorded on the 
cage. After five to ten days those females which had not demon-
strated copulations plugs were removed from the cages and the 
process of isolation of the males follO\ved by mating was again 
repeated. 
On the 12th day following copulation the females were again 
weighed and those which had gained approximately 2 gm. or more 
were considered pregnant and ready for injection. 
D. Preparation of Stock Solution 
Cortisol - 1,2lti was obtained from Nuclear Chicago in 1 ml. 
benzene-ethanol (9:1 v/v) suspension, vacuum sealed glass vials. 
The specific activity was 1 millicurie (mCi) per milliliter (ml.) 
(46.7 Ci)m mol.). The vials were opened and the contents placed 
into injection vials which were then sealed with a rubber stopper 
and refrigerated for storage. Each day as the solution WJ5 
required, the appropriate volume was withdrawn from the storage via1 
with a 1 cc. tuberculin syringe and placed in another injection 
vial. The benzene-ethanol suspension was evaporated usi~g an 
indirect air stream and sterile normal saline was added to give a 
concentration of 50 uCi per .05 cc. 
E. Injection Procedures 
Eight animals were given a loading dose of 0. 1 cc. of 2.5% 
cortisone acetate S.A.S. (sterile aqueous solution) (total dose 
2.5 mg.) intramuscularly in the hamstring muscle of the left leg. 
This was followed 30 minutes later by an injection of cortisol 
(hydrocortisone) - 1,2 tritium. Two animals were both given 250 uCi 
(containing a total dose of .0021 mg.) and the remaining six were 
given 50 uCi (containing a total dose of .00042 mg.). Five animals 
were each given 50 uCi of labeled cortisone without a loading dose. 
The animals were sacrificed one hour after the injection of 
the isotope. The carotid artery was severed and blood collected 
in a . 1 cc. heparinized capillary tube. The uteri were removed 
with the embryonic sacs and the fetuses intact. Maternal livers, 
spleen, kidney, adrenals, heart, tongue, brain and palatal mucosa 
were dissected out. Then with the aid of a binocular dissecting 
microscope, the placentas and fetuses were separated and the fetal 
liver and heart, jaws, tongues and brain isolated. Al I the speci-
mens were placed on pieces of preweighed Whatman number 4 filter 
paper and bench dried for 24 hours before the dry weights were 
obtained. 
F. The Packard Tri-Carb Sample Oxidizer Method 
The sample is placed in a platinum combustion basket in a 
preheated combustion chamber. A constant flow of oxygen is intro-
duced into the chamb~r and the sample is ignited by heating the 
platinum basket with an electric current. The water is trapped by 
cooling it to o° C. After combustion the oxygen is displaced from 
the system by a nitrogen purge and a preselected volume of scintil-
lator is dispensed from a nitrogen purged reservoir into the 
counting vial. A final nitrogen purge is used to obtain a nitrogen 
atmosphere in the vial before the cap is secured. The instrument 
is also fitted with a steam purge to reduce the "memory effect. 11 
G. Counting Technique 
Counting was done in a Beckman DPM 100 ambiant temperature 
liquid scintillation counter. The scintillator recipe was as 
follows: Napthalene - 100 gm., P.P.O. - 5 gm., Dimethyl P.O.P.O.P. -
0.3 gm., Dioxane - 720 ml., Toluene - 135 ml., and Absolute 
Methanol - 45 ml. This cocktail wil 1 take up to 10% water. 
15 ml. aliquots were used and placed in low potassium glass vials. 
Tritiated toluene was used as a reference standard for determining 
the counting efficiency. Background was determined by counting 
blank vials before running the tissues. Efficiency for tritium, 
following oxidation in the Packard Model 305 Tri-Carb sample 
oxidize~was approximately 40% and the background was about 25 
counts per minute. 
CHAPTER 4 
FINDINGS 
The animals in the order in which they were sacrificed, the date 
of sacrifice, weight gain, amount of label and loading dose were all 
recorded and this data is shown in Table 1. 
A. Relative Distribution of Label in Various Maternal and Fetal Tissues 
The weights of the various tissues after drying at room tern-
perature for 21, hours are shown fol lowed by the raw c.p.m. (counts 
per minute) per sample; d.p.m. (decays per minute) per sample; 
d.p.m. per mg. and microcuries X 163 per mg. (see Table 2 in 
Appendix). In each case the entire organ was used for counting 
except in the case of the livers. The livers were too large to be 
oxidized in the tri-carb oxidizer and counted in total, so only a 
portion was used. The weights of liver segments oxidized along with 
the total dry weights of the livers are recorded. The d.p.m. per 
sample was determined by subtracting the background from the c.p.m. 
per sample and then multiplying by the efficiency. The efficiency 
was determined, as stated in the method, by adding a known number 
of d.p.m. in the form of tritiated toluene to a blank counting vial 
and observing the c.p.m. 
Efficiency = c.p.m. Tritiated Toluene X 100% Known d.p.m. of Tritiated Toluene 
----------------------~ ~'>~ 1 
TABLE 1 
Labeling 
Weight on Loading Dose Dose ~hr. 
Mouse# in Weight on Day of Net of Co rt i sone before 
Order of Date of Day of Sacrifice Gain 1 hr. before Sacrifice 
Sacrifice Sacrifice Copulation in gm. in gm. Label in mg. in uC i 
1 Dec. 3 21. 2 23.0 1. 8 2.5 250 
2 Dec. 3 19.5 21.0 1. 5 2.5 250 
3 Dec. 6 20.5 24.6 4. 1 2.5 50 
4 Dec. 6 20.6 25.5 4.9 2.5 50 
5 Jan. 30 19.9 22.6 2.7 50 
6 Jan. 30 21. 8 25.0 3.2 50 
7 Jan. 30 21. 6 25.0 3.4 50 
8 Feb. 2 20.5 23.3 2.8 50 
9 Feb. 7 20.0 23. 8 3.8 50 
10 Feb. 15 21. 5 23.7 2.2 2.5 50 
11 Feb. 15 22.7 24. 1 1.4 2.5 50 
12 Feb. 17 21. 3 25.6 4.3 2.5 50 
13 Feb. 17 21. 7 24.4 2.7 2.5 50 
The Placentas were numbered beginning at the right terminal 
of the uterus and proceeding around to the left terminal. Unless 
otherwise indicated in the table the blood volume was 0. 1 ml. 
The first two animals (one of which was not pregnant) were 
given a loading dose of 2.5 mg. of cortisone, followed one-half 
hour later by 250 uCi (microcuries) of label. Results indicated 
that this was more label than needed to obtain significant counts 
in both maternal and fetal tissues. Thereafter, it was decided 
to use only 50 uCi label per animal and these two animals were not 
included in the statistical analysis. 
The mean uptake values in each of the tissues in uCi X 16 3 
per mg. followed by the standard deviation for each group was 
figured and these results are shown in Table 3(a & b). 
Analysis of variance (Table 4a) indicates that within both 
loading and nonloading groups, the uptake in the maternal livers 
was significantly higher than in all of the other tissues except 
the kidney. There was no significant difference between the liver 
and kidney uptakes within either of the groups (as determined by 
studentized range test). Within the two groups there was no sig-
nificant difference in the uptake in the different fetal tissues. 
However, there was a significant difference between animals within 
each group both in the fetal and maternal uptakes. 
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Tissue 
Tongue 
Spleen 
Palatal Mucosa 
Liver 
Brain 
Kidney 
Heart 
Adrenal 
Blood 
Right 
Left 
Tongue 
Jaws 
Brain 
Liver & Heart 
Right Remainder 
Left Remainder 
TABLE 3(a) 
50 uCi TRITIATED CORTISOL 
NO LOADING DOSE 
(uCi X 10 3) Mean 
mg 
Maternal 
1. 414 
1.240 
1. 752 
14.398 
0 .277 
8.988 
2. 143 
2.019 
3.915 
Placenta 
4. 119 
3.860 
Fetal 
2.091 
1. 673 
1. 449 
2.281 
1. 820 
1. 751 
Standard Deviation 
1. 288 
1. 195 
1 . 112 
12.873 
0. 160 
9.070 
2.058 
2.405 
3. 775 
2.964 
2.926 
1. 572 
1. 379 
1. 439 
1.881 
1. 111 
1. 530 
TABLE 3(b) 
50 uCi TRITIATED CORTISOL 
+A LOADING DOSE OF 2.5 mg "COLD'' CORTISOL 
Tissue 
Tongue 
Spleen 
Palatal Mucosa 
Liver 
Brain 
Kidney 
Heart 
Adrenal 
Blood 
Right 
Left 
Tongue 
Jaws 
Brain 
Liver & Heart 
Right Remainder 
Left Remainder 
(uCi X 103) Mean 
mg 
Materna 1 
0.367 
0.323 
0.351 
3. 568 
0.059 
1. 646 
0.463 
o. 702 
0.936 
Placenta 
1. 251 
1. 242 
Fetal 
0.486 
0.540 
0.468 
0.822 
0.678 
0.548 
Standard Deviation 
0. 148 
0. 140 
0. 143 
1.452 
0.024 
0. 730 
0.225 
0.516 
0.461 
0.602 
0.646 
0.371 
0.283 
0.218 
0.495 
0.369 
0.356 
TABLE 4(a) 
MATERNAL ANALYSIS OF VARIANCE 
Source of Variance DF 
Maternal Load vs. Non-Load 
Maternal Non-Load 
Tissues 
Animals 
Interaction (animals X tissues) 
8 
4 
32 
Materna I Load 
Tissues 
Animals 
Interaction (animals X tissues) 
8 
5 
40 
Tota 1 98 
,., Significant at the P < 0.01 level. 
MS 
22 7. 176 
109.866 
124.502 
19.0135 
7. 142 
1. 269 
0.2453 
F 
826. 457'" 
5, 77 "' 
6. 548'" 
29.116''' 
5.173"' 
TABLE 4(b) 
FETAL ANALYSIS OF VARIANCE 
Source of Variance 
Fetal Load vs. Non-Load 
Tissues 
Animals 
DF 
Fetal Non-Load 
Interaction (animals X tissues) 
5 
4 
20 
Fetal Load 
Tissues 
Animals 
Interaction (animals X tissues) 
5 
5 
25 
Total 65 
*Significant at the P < 0.01 level. 
MS 
26.68 
0.445 
12.885 
0. 1344 
0. 166 
0.663 
0.022 
F 
371.190;" 
3. 311 
96. 58 ;'< 
7. 545-l< 
30. 136;'< 
TABLE 4(c) 
PLACENTAL ANALYSIS OF VARIANCE 
uCi X 103 
mg. 
15 
10 
5 
0 
l-
(!) 
> 
_J 
FIGURE 1 
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In both groups there was a significantly hi~her uptake in the 
maternal tissues than in the fetal tissues (determined by student 
11T11 test P .01). This would suggest that there is not free 
interchange between the mother and fetuses but that some type of 
placental barrier exists. Since the ratio of fetal uptake to 
maternal uptake in each group (loading and nonloading) was about 
the same, it would appear that the loading dose did not affect 
the placental barrier. 
In both the maternal and the fetal tissues there was a 
statistical significant difference between the uptake in the two 
groups. The uptake was much higher in the nonloading group than 
in the loading group (Table 4a & b). 
The mecin uptakes in the placentas from the right and left 
side of the uterus as shown in Table 3(a & b) indicate that there 
was no significant difference between right and left sides in 
either of the two groups (Table 4c). 
CHAPTER 5 
DISCUSSl0N 
A. The Tri-Carb Oxidizer and Liquid Scintillation Counter 
The Tri-Carb oxidizer used in conjunction with the liquid 
scintillation counter provides an easy and accurate means of 
measuring the amount of tritium activity in very minute amounts 
of biological material. It reduces the possibility of error which 
is common to other techniques and in addition is much faster. 
Unlike autoradiography it can be used for accurate quantitative 
studies. Marks and Schmitz, using the same amount of activity as 
was used in the present study, had difficulty finding significant 
counts in some of their specimens, while we had no such problem. 
Admittedly, the failure of finding highly significant label by 
Marks and Schmitz may have been due to waiting too long after 
injection of label before sacrificing. 
B. Drying and Weighing 
Drying and weighing procedures were not nearly as accurate as 
the counting. Tissues were bench dried at room temperature and 
humidity. The humidity may have fluctuated considerably from one 
day to another. Larger specimens undoubtedly were not as dry as 
smaller ones at the time of weighing. The filter paper used to hold 
the tissue weighed between 110 and 120 mg. while a few of the 
fetal tissue samples weighed less than mg. Thus the moisture 
content of the filter paper, which was a function of the relative 
humidity, could be responsible for a relatively large error in 
the weight of the specimen. Later on in the study the size of 
the filter paper used with the fetal tissues and placentas was 
reduced to between 30 and 40 mg. Also, it was found that the 
balance used for weighing was only accurate to 0.5 mg., although 
it was calibrated in tenths of a mg. 
C. Preparatipn of Injection Solution from Stock Solution and 
Measurement of Dose 
As stated earlier, a tuberculin syringe was used to withdraw 
the ethanol-benzene suspension of tritiated cortisol from the 
stock solution and to place it in an injection vial as required 
each day. The ethanol-benzene suspension was then evaporated off 
and normal saline added to produce a concentration of 50 uCi per 
0.05 cc. 0.05 cc. of this solution was then injected into each 
animal. ·The tuberculin syringe had a 1 cc. capacity at full 
scale and thus was not very accurate for measuring 0.05 cc. 
Early in the study plastic disposable syringes were used but these 
were replaced in favor of glass ones which were not as susceptible 
to surface absorption and thus more reliable. 
Considerable error probably resulted from evaporating the 
ethanol-benzene suspension leaving dry cortisol powder under a 
stream of air. Some of the powder may have been lost at this 
time. A more accurate method would be to prepare the injection 
solution at one time. Then a small aliquot could be counted and 
the specific activity of the injection solution could be determined. 
This was not done because it was not known whether the tritiated 
cortisol would be stable in the saline solution. It would also 
be better to use the same syringe for all the injections as this 
would eliminate the error due to differences in syringes, i.e., 
surface absorption. 
D. Significance of Different Uptakes in Different Animals and 
Different Tissues · 
The different uptakes between animals within the same group 
were probably due to differences in the physiology and differences 
in the dosage. The reasons for inaccuracies in the dosage have 
been discussed earlier. Because of the apparent inaccuracies in 
the dosages we were unable to show the percent of the dose taken 
up by the various tissues. The high concentration of label in the 
maternal liver and kidney probably represents the detoxification 
and excretion of cortisone by these organs. 
I 
I 
I 
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E. Placental Barrier 
The greater uptake in maternal tissues than in fetal tissues 
would tend to support the concept of a partial placental barrier 
to cortisone, and is in agreement with the findings of Hanngren et 
al, and Nasjleti et al. However, the difference may have been due 
to differences in the metabolism of the maternal and fetal tissues 
rather than to a placental barrier; but this is unlikely because 
there was no significant difference in label uptake among the 
fetal tissues. It is interesting to note that the loading dose 
did not affect the ratio of fetal uptake to maternal uptake. The 
extremely poor uptake by the maternal brain is probably due to the 
brain blood barrier. Apparently, though, there is sti 11 free 
interchange between the fetal blood and brain at this stage of 
fetal development. 
F. Effects of Loading Dose 
The loading dose as used by Marks and Schmitz did not enhance 
the uptake of label but rather lessened it. They hypothesized 
that ''cold 11 cortisone given one-half hour before the 11hot 11 cortisol 
would overload the metabolic processes responsible for its break-
down and thus the labeled material would remain unmetabolized for 
a longer time and would accumulate in the tissues. The results of 
this study indicate that the uptake In the animals which were not 
given a loading dose is about three times what it is when a loading 
dose is used. 
G. Right vs. Left 
There is equal uptake in right and left sides of the placenta. 
This again is contrary to the finding of Marks and Schmitz, but 
their findings were obtained from autoradiographic studies and it 
is difficult to obtain reliable quantitative studies in an auto-
radiographic study where many specimens are used. 
H. Feasibility of Chromatographic Studies 
The average weight of the fetal jaws from one mouse was 
about 7 mg., and the mean uptake in the fetal jaws was about 
1.673 X ·163 uCi/mg. or 11.711 uCi X 16 3 per mouse fetal jaw 
tissue. The specific activity of 
46.7 Ci perm. mol., or 1 uCi per 
the 1abe1 ed 
166 
%:=[ m mol. 
cortisol was 
This means that 
the fetal jaw tissue from one pregnant mouse would contain 
approximately 0.25 X 169 m. mol. of cortisone, assuming that al 1 
of the label represents cortisone. This figure can be used as a 
guide in future chromatographic studies. It is obvious that a 
very sensitive technique will have to be used. It may be necessary 
to use all the fetal tissue from one mouse in order to have suffi-
cient cortisone for chromatographic analysis. It must be remembered 
that in our present study we have detected label only and complete 
chromatographic analysis of maternal and fetal tissues will be 
necessary to demonstrate how much of the label is still cortisone. 
Our study does show that sufficient label is present and that these 
chromatographic studies would seem feasible. 
I. Time - Uptake Study 
Judging from the results of this study as well as from the 
findings of previous investigators it appears that one hour post 
injection is a better time for sacrifice than five hours as Marks 
and Schmitz did. However, a time - upt~ke study is needed to 
determine the time that a sign; ficant level of cortisone is 
present in the various tissues. 
I 
I 
I 
I 
I 
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CHAPTER 6 
SUMMARY AND CONCLUSIONS 
Pregnant mice were giv~n tritiated cortisol on the 12th day of 
gestation, and sacrificed on~ hour later. The maternal tongue, spleen, 
palatal mucosa, 1 iver, brain, kidney, heart, adrenals and blood; and 
the fetal tongue, jaws, brain and placentas were oxidized in a Packard 
Tri-Carb oxidizer and counted in a liquid scintillation counter. 
Pertinent findings were: 
a. No significant difference in the uptake in the various 
maternal tissues except for the liver and no significant 
difference in the uptake in the various fetal tissue. 
b. A significantly higher uptake in maternal than in fetal 
tissues, suggesting the presence of a placental barrier. 
c. The loading dose as used by Marks and Schmitz hinders 
rather than improves the uptake of label injected later. 
d. There is no significant difference in uptake in placentas 
on the right and left sides of the uterus in contrast to 
that described by Marks and Schmitz. 
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The Packard Tri-Carb oxidizer used in conjunction with a liquid 
scintillation counter is an easy, accurate and efficient way of 
measuring uptake of tritium label in biologic specimens. 
More accurate techniques for preparing the labeled material for 
injection and measuring the dose are needed. This would reduce the 
amount of variance in the study and possibly would show significant 
differences in the uptakes in various tissues which could not be 
shown at this time. 
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CHAPTER 8 
APPENDIX 
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TABLE 2(a) 
MOUSE #1 
EFFICIENCY - 38%, BACKGROUND - 25 COUNTS PER MINUTE 
LOADING DOSE+ 250 uc* 
Maternal 
Net Wt. Raw Counts Decays Per Decays Per 
(r.ig) Per Minute Minute/Sample Minute/mg 
Tongue 18. 9 50. 19 3 132,021 6,985 
Spleen 26.5 5/,014 149,971 5,659 
Palate 0.4 5,501 14,411 36,026 
Liver 140.5 2,877,000 7,570,986 53,886 
Total Liver ";'\";~ 
Brain 86.5 34,312 90,229 1 ,0113 
Kidney 76.0 750,308 1,974'429 25,979 
Heart 20.9 66,232 174,229 8,336 
Adrenals 3.6 21,387 56,216 15,615 
Blood 18.5 114,771 301 ,963 16,322 
Placenta 
1 ·'/\.;'\;':: 2.8 45' 129 118,695 42,391 
2 ;~·k··k 3.9 59,354 156,128 40,033 
3 -l\ ;'::-;':: 4. 1 52,520 138,145 33,694 
4 'i'::;':.·k 2.5 34' 146 89 '792 35,917 
5 ;'\·}::t':: 4.0 53,323 140,257 35,064 
6 -;'\ .. k;':: 1. 3 20,642 54,255 41 '735 
7 ";"";'::·}:: 5.0 49,378 129,876 25,975 
8 2.9 31 '570 83,013 28,625 
Fetal 
Tongue 1.0 2,464 6,418 6,418 
Jaws 7.4 6,230 16,329 2,206 
Brain 6.9 5,737 15,032 2' 178 
Liver & Heart ·k·k.i'\;'\. 
R. Remainder 5.3 32,546 85,581 16,147 
L. Remainder 1.0 8,740 22 ,934 22,934 
UC x 10/mg 
3. 15 
2.55 
16.23 
24.27 
.470 
11. 70 
3.76 
7.03 
7.35 x 
19.09 
18.03 
15. 18 
16. 18 
15.79 
18.80 
11 . 70 
12.89 
2.89 + 
.994 + 
.981 + 
7.27 
10.33 
~~ Mi crocuri es 
** Total Weight Not Obtained 
*** Intra-uterine Order Unknown 
****These tissues were not obtained 
as separate specimens 
X B 1 ood Vo 1 ume Unknovm 
+Approximate Weight 
...
. ,.·' 
-----------------------------------
____ __,, ____________ .. _,.,.,. _______________ ....., 
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I TABLE 2(b) 
MOUSE #2 I 
I 
I 
EFFICIENCY - 38%, BACKGROUND - 25 COUNTS PER MINUTE 
I 
I 
LOADING DOSE + 250 uc 
Net Wt. Raw Counts 
(mg) Per Minute 
Tongue 28.9 21 ,695 
Spleen 10.0 7,820 
Palate 1. 5 2,420 
Liver 166.5 1'389 ,000 
Total Liver i~ ;'~ 
Brain 88.0 11,437 
Kidney 90.0 209,785 
Heart 23.5 22,633 
Adrenals 4.5 6 ,892 
Blood 34.2 50,599 
** Total Weight Not Obtained 
X B 1 ood Vo I ume Unknovm 
Maternal 
Decays Per 
Minute/Sample 
57,026 
20,513 
6 ,303 
3,655, 197 
30,032 
552,000 
59,495 
18,071 
133 ,089 
~--------
Decays Per 
Minute/mg UC 
1 ,973 
2,051 
4,202 
21,953 
341 
6' 133 
2,532 
4,016 
3,892 
X 10 3 /mg 
. 889 
.924 
1. 89 
9.89 
. 154 
2.762 
1. 14 
1. 81 
1.75 x 
TABLE 2(c) 
MOUSE #3 
EFFICIENCY - 40.09%, BACKGROUND - 30 COUNTS PER MINUTE 
LOADING DOSE+ 50 uc 
Maternal 
Net Wt. Raw Counts Decays Per Decays Per 
(mg) Per Minute Minute/Sample Minute/mg UC 
Tongue 22.2 4,549 11,272 508 
Spleen 32.2 5,204 12,905 400 
Palate 2.8 539 1 ,269 453 
Liver 71. 5 2,632,500 6,566,400 91,838 
Total Liver 382.7 
Brain 58. 1 1 ,640 4,016 691 
Kidney 89.7 82' 195 204,951 2,284 
Heart 28. 1 6 '132 15,220 542 
Ad renal 7.2 3,860 9,554 1, 326 
Blood 21. 1 11 '2 73 28,044 1'329 
Placenta 
1 9.7 9,829 24,443 2,520 
2 8. 1 6,429 15 '962 1 ,9 71 
3 15.0 16,759 41'729 2,782 
4 8.7 6,506 16' 154 1'857 
5 17. 2 20,837 51 ,901 2,966 
6 5. 1 2,779 6,857 1'345 
7 4.3 3 '726 9,219 2' 144 
8 5.7 3' 144 7,768 1 ,363 
9 ;" 4.2 3,430 8,481 2,019 
10 3.0 2,911 7' 186 2,395 
Fetal 
Tongue 1. 7 857 2,063 1 '213 
Jaws 8.9 3,235 7,995 898 
Bra in 8.4 2 '742 6,765 805 
Liver & Heart "'k;": 
R. Remainder 2 1. 1 6,098 52,891 2,507 
L. Remainder 12.3 4 '122 10,207 830 
X Blood Volume 0. 1 ml. 
*Nonviable fetus 
** These tissues were not obtained as separate specimens 
-3 X 10 /mg 
.229 
. 180 
.204 
41. 3 
.031 
1.03 
.244 
. 598 
.599 x 
1. 135 
.888 
1. 253 
.836 
1. 336 
.606 
.966 
.614 
.910 
1.079 
.547 
.405 
.363 
1. 129 
. 374 
TABLE 2(d) 
MOUSE #4 
EFFICIENCY - 40.09, BACKGROUND - 30 COUNTS PER MINUTE 
LOADING DOSE + 50 uc 
Maternal 
Net Wt. Raw Counts Decays Per Decays Per 
(mg) Per Minute Minute/Sample Minute/mg 
Tongue 29. 1 12,673 31 '536 1 ,084 
Spleen 31. 3 13,036 32,442 1 ,0 36 
Pala le 2.4 1 '170 2,844 1 '185 
Liver 33.5 146,550 365,545 10,911 
Total Liver 472.0 
Brain 124.4 8,695 21,613 174 
Kidney 96. 1 203,327 507,102 5,277 
Heart 29.4 17,262 42,983 1 ,462 
Adrenal 6.3 6,026 14,956 2,374 
Blood 22.7 33,316 83,028 3,658 
Placenta 
1 3.8 5,632 13 ,974 3 ,677 
2 5.8 9 452 23 502 4 052 
3 7.4 11 '764 29,269 3,955 
4 1 1. 2 18,624 46,380 4, 141 
5 6.0 9,631 23,949 3,991 
6 6.9 8,464 21,037 3,049 
7 9.3 21,953 54,684 5,880 
Fetal 
Tongue 1. 0 1 ,076 2,609 2,609 
Jaws 7.4 6,251 15,518 2,097 
Brain 6.9 4,662 11 '554 1,675 
Liver & Heart 1. 3 1'478 3,612 2' 778 
R. Remainder 8.2 7,525 18,695 2 ,280 
L. Remainder 14.0 14,503 36' 101 2' 579 
X Blood Volume 0. 1 ml 
UC X 103/mg 
.488 
.467 
.534 
4.915 
.078 
2.38 
.659 
1. 07 
1. 65 ~ 
1. 656 
1. 83 
1. 78 
1. 87 
1. 80 
1. 37 
2.64 
1. 175 
.945 
. 754 
1. 252 
1. 027 
1. 162 
TABLE 2(e) 
MOUSE #5 
EFFICIENCY - 39.62, BACKGROUND 35 COUNTS PER MINUTE 
Tongue 
Spleen 
Palate 
Liver 
Total Liver 
Brain 
Kidney 
Heart 
Adrenal 
Blood 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Tongue 
Jaws 
Brain 
Liver 
R. Remainder 
L. Remainder 
Net Wt. 
(mg) 
35,3 
31. 5 
1. 8 
35.8 
340.0 
90.8 
84.4 
29.0 
4.0 
15.5 
5. 1 
2. 1 
2.6 
6.4 
7.8 
5.2 
4.7 
3,3 
4. 1 
1. 3 
3,7 
4.0 
1. 8 
9,9 
8.2 
X Blood Volume .07 ml 
NO LOADING DOSE + 50 uc 
---
Maternal 
Raw Counts Decays Per 
Per Minute Minute/Samele 
103,054 260,018 
84,957 214,341 
5,494 13 '778 
975,860 2,462,960 
33,336 84,051 
1 , 716' 600 4,332,651 
12 7 '962 322,885 
22,060 55,591 
128,877 325' 194 
P 1 acenta 
29,309 73,887 
14,904 37,530 
13,357 33,624 
48,431 122' 150 
69,972 176,519 
44,432 112,057 
25,923 65,340 
19,289 48 '596 
29,620 74 '6 72 
Fetal 
4,923 12,337 
11 '902 29,952 
13' 146 33,091 
7,854 19,735 
31 , 384 79, 124 
28,334 71 ,426 
~-----
Decays Per 
Minute/mg UC 
7,366 
6,804 
7 ,655 
68,798 
926 
51 '334 
11 ' 1 34 
13,898 
20,980 
14,488 
17,871 
12,932 
19,086 
22,630 
21 '549 
13,902 
14,726 
18,212 
9,490 
8 ,095 
8,273 
10 ,964 
7,992 
8,710 
-3 X 10 /mg 
3.32 
3,07 
3.45 
30.99 
.417 
23. 124 
5.02 
6.26 
9.45 x 
6.53 
8.05 
5.83 
8.60 
10. 19 
9.70 
6.26 
6.63 
8.20 
4.27 
3.64 
3,73 
4.94 
3.60 
3.92 
X Blood Volume 0. 1 ml 
* Fetal Resorption 
~---------------~--
TABLE 2(g) 
MOUSE #7 
EFFICIENCY - 39.62%, BACKG ROUND - 35 COUNTS PER MINUTE 
NO LOAD I NG DOSE + 50 UC 
Maternal 
Net Wt. Raw Counts Decays Per Decays Per 
X 10 3 /mg (mg) Per Minute Minute/Sample Minute/mg UC 
Tongue 29.5 27,167 68,481 2,321 1. 05 
Spleen 31.6 24,287 61,212 1 ,937 .873 
Palate 2.0 3,497 8, 738 4,370 1. 97 
Liver 93.8 767,359 1,936,709 20,647 9,30 
Total Liver 318.0 
Brain 87.4 15,300 38,528 441 . 199 
Kidney 96.3 425,025 1,072,665 11 '139 5.02 
Heart 42.9 53,5S1 135 ,073 3' 149 1. 42 
Adrenal 2.7 2,625 6,537 2,421 1. 09 
Blood 23.6 49,064 123,748 5,244 2.37 x 
Placenta 
-
5. 1 22 '113 55' 724 10,926 4.92 
2 
3 6. 1 14, 133 35,583 5,833 2.63 
4 7.0 17,866 45,005 6,429 2.89 
5 2.0 4 ,270 10,689 5,344 2.41 
6 4. 1 13,081 32,928 8 ,031 3.62 
7 4. 1 12,037 30,293 7,388 3.33 
8 2.7 7,654 19,230 7' 122 3.21 
9 3.2 10,098 25,399 7,937 3.58 ·k. 
Fetal 
Tongue 1. 6 2' 170 5,389 3,368 1. 52 
Jaws 2.3 2,735 6,815 2 ,963 1. 33 
Brain 5.9 4,681 11 '72 7 1 ,988 . 895 
Liver & Heart 3. 1 6' 163 15,467 4 ,989 2.25 
R. Remainder 7.4 9,631 24,220 3 ,273 1. 47 
L. Remainder 5,7 6,577 16,512 2.897 1. 30 
x Blood Volume 0. 1 ml 
i~ Resorption 
.:~ .......... ______________________________ .-
TABLE 2(h) 
MOUSE #8 
EFFICIENCY - 39.62%, BACKGROUND - 35 COUNTS PER MINUTE 
Tongue 
Spleen 
Palate 
Liver 
Total Liver 
Brain 
Kidney 
Heart 
Adrenal 
Blood 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Tongue 
Jaw; 
Brain 
Liver & Heart 
R. Remainder 
L. Remainder 
Fetus #6 
Net Wt. 
(mg) 
31. 5 
29.9 
1. 7 
42. 1 
492.0 
106.8 
83.0 
25.5 
1. 9 
23.7 
4.9 
5.4 
5.6 
2.0 
4.7 
4.6 
4.3 
3.6 
4. 1 
0.4 
4.7 
4.3 
2.0 
1. 2 
16.5 
7.3 
X Blood Volume 0. 1 ml 
f, Resorption 
NO LOADING DOSE + 50 uc 
Maternal 
Ra·, Counts 
Per Minute 
8 ,417 
6,047 
777 
100,048 
3,304 
163,751 
7,517 
1 ,209 
15,047 
Decays Per 
Minute/Sample 
21 , 156 
15, 174 
1'873 
252,431 
8,251 
413,216 
18,884 
2 ,963 
37,890 
Placenta 
3 ,240 
3' 166 
3 ,496 
2,000 
3,039 
3,782 
2,885 
1 ,939 
2 '103 
167 
1 '526 
954 
691 
1 ,468 
5,457 
4,586 
Fetal 
8 ,089 
7,903 
8, 735 
4 ,960 
7,582 
9,457 
7, 193 
4 ,805 
5,220 
333 
3' 763 
2,320 
1 ,656 
3,617 
13,685 
11 ,487 
~-------
Decays Per 
Minute/mg 
671 
507 
1 '102 
5,996 
77 
4,979 
740 
1, 559 
1 ,599 
1 ,650 
1 ,463 
1'560 
2,480 
1 '61 3 
2,055 
1 ,673 
1'335 
1,273 
833 
801 
539 
828 
3,014 
829 
1, 574 
.303 
.229 
.497 
2.70 
.0348 
2.24 
.334 
. 703 
. 720 x 
.744 
. 659 
.703 
1. 12 
. 727 
. 926 ;'~ 
.754 
.601 
.573 
.375 
.361 
.243 
.373 
1. 36 
.374 
. 709 
TABLE 2(i) 
MOUSE #9 
EFFICIENCY - 39.62%, BACKGROUND - 35 COUNTS PER MINUTE 
NO LOADING DOSE + 50 UC 
Mate ma 1 
Net Wt. Raw Counts Decays Per Decays Per 
-3 (m~) Per Minute Minute/Sample Minute/mg UC X 10 /mg 
Tongue 28.9 8' 142 20,462 708 .319 
Spleen 28.5 6,840 17' 1 76 603 . 271 
Palate 11. 9 644 1 ,537 129 .0582 
Liver 60.7 210,455 531 ,095 8,750 3.94 
Total Liver 359.0 
Brain 128. 5 4,609 11 '545 898 .040 
Kidney 88.7 134, 157 338,521 3,816 1. 72 
Heart 33.9 12,557 31 ,605 932 .420 
Adrenal 2.9 1 ,284 3' 152 1 ,087 .490 
Blood 23.8 19,352 48,756 2,049 . 923 x 
Placenta 
1 7.5 10,247 25 '775 3,437 1. 55 
2 5.8 9,043 22,736 3,920 1. 77 
3 8.0 15 '830 39,866 4 ,983 2.24 '"k. 
4 1. 7 5,960 14,955 8, 797 3.96 
5 6. 1 2,241 5,568 913 . 411 
6 6.5 6,571 16 '49 7 2,538 1. 14 
7 5.3 5,470 13,718 2,588 1. 17 
8 5.5 5,386 13,506 2,456 1. 11 
9 7.0 7,009 17,602 2,515 1 . 13 
Feta 1 
Tongue 0.9 972 2 ,365 2,628 1. 18 
Jaws 9.6 4 '725 11,837 1,233 .555 
Brain 8.4 3' 141 7,839 933 .420 
Liver & Heart 5.3 3' 113 7,769 1 ,466 .660 
R. Remainder 7.2 4' 103 10,268 1'426 .642 
L. Remainder 16.9 6,904 17,337 1 ,026 .462 
x Blood Vo 1 ume 0. 1 ml 
;"\ Fetal Resorption 
If .. J ' TABLE 2(j) 
I 
,, 
MOUSE #10 
EFFICIENCY - 41. 73%' BACKGROUND - 25 COUNTS PER MINUTE 
LOADING DOSE + 50 UC 
Materna 1 
Net Wt. Raw Counts Decays Per Decays Per 
-3 (mg) Per Minute Minute/Sample Minute/mg UC X 10 /mg 
Tongue 19.8 8 'li64 20 '22 3 1 '021 .460 
Spleen 24.2 7,605 18' 164 750 .338 
Pa 1 ate 2.2 883 2,056 935 .421 
Liver 30.2 97,635 233,908 7,745 3.489 
Total Liver 385.4 
Brain 98.4 6 ,696 15,986 162 .073 
Kidney 93.9 140,261 336,055 3 ,579 1. 612 
Heart 29. 1 16,538 39,571 1'360 .613 
Adrenals 5.5 7,919 18,915 3,440 1. 549 
Blood 23.8 24,443 58,514 2,458 1. 107 
Placenta 
----
1 5.6 7,221 17 ,244 3 ,079 1.387 
2 11. 9 18,731 44,826 3,767 1.697 
3 5.2 5,546 13,230 2,544 1. 146 
4 9.9 13' 129 31 ,401 3' 172 1. 429 
5 7.0 6,991 16,693 2,385 1. 074 
6 6. 1 7,370 17,601 2,885 1. 300 
) 3. 1 2 '745 6,518 2' 103 .947 
8 5.8 7,469 17,838 3,075 1. 385 
Fe ta 1 
Tongue 1. 1 459 1 ,040 946 .426 
Jaws 5,9 2,726 6,473 1 ,097 . 494 
Brain 5.9 2,422 5 '744 974 .439 
Liver & Heart 3.5 2 '183 5' 171 1 ,477 .666 
R. Remainder 10.2 5,463 13,031 1 ,278 . 575 
L. Remainder 4.0 2,038 4,824 1 ,206 .543 
45 Minutes between Loading Dose and Labeled Dose 
.. ________________________ _.....-
TABLE 2(k) 
MOUSE #11 
EFFICIENCY - 41 .73%, BACKGROUND - 25 COUNTS PER MINUTE 
LOADING DOSE + 50 uc 
Maternal 
Net Wt. Raw Counts Decays Per Decays Per 
X 10 3/mg (mg) Per Minute Minute/Sample Minute/mg UC 
Tongue 38.2 19,117 45,751 1 '198 .539 
Spleen 27.9 12,018 28,739 1 ,030 ·.464 
Palate 2.2 951 2,219 1 ,008 .454 
Liver 38.3 181,023 433,736 11 '325 5. 101 
Total Liver 385.7 
Bra i r. 111 . 0 8,952 21 '392 193 .087 
Kidney 90.4 218' 186 522 '791 5,783 2.605 
Heart 31. 0 20,668 49,468 1'596 .719 
Adrenals 7.4 3,549 8,445 1 ' 141 .514 
Blood 26.3 28' 770 68,883 2,619 1. 179 
Placenta 
1 3,3 4,808 11 '462 3,473 1. 564 ;'-;. 
2 6.7 18,383 43,992 6,566 2.957 
3 5.2 9 ,010 21 ,531 4' 141 1. 865 
4 6.6 12,193 29' 159 4,418 1. 99 
5 9,7 16,616 39,758 4,099 1. 846 
6 5.6 10 '636 25,428 4,541 2.045 
7 7,5 15 '5 72 37,256 4,967 2.238 
8 3.8 5,458 13,019 3,426 1. 54 3 
Feta 1 
Tongue 0.8 329 728 911 .410 
Jaws 5.0 3,844 9' 152 1'830 . 824 
Brain 6.5 4,263 10' 156 1 ,562 . 704 
Liver & Heart 3.2 4,601 10,966 3 ,427 1. 544 
R. Remainder 8. 1 5,936 14,165 1'749 .788 
L. Remainder 7.3 4,893 11 '66 5 1'598 . 720 
~·, Fetal Re so rpt ion 
TABLE 2(1) 
MOUSE #12 
EFFICIENCY - 41. 73% - BACKGROUND - 25 COUNTS PER MINUTE 
LOADING DOSE + 50 UC 
Maternal 
Net Wt. Raw Counts Decays Per Decays Per 
X 16 3/mg (mg) Per Minute Minute/Sample Minute/mg UC 
Tongue 46.7 8' 108 19,370 415 . 186 
Spleen 35.2 4,443 10,587 300 . 135 
Palate 2.2 387 867 394 . 178 
Liver 17.5 23,425 56,075 3,204 1. 44 3 
Total Liver 478.2 
Brain 92.6 2,585 6 '135 66 .030 
Kidney 115. 0 79,984 191,610 1'666 ,751 
Heart 31. 1 6,504 15,526 499 .225 
Adrenal 2.4 437 987 411 . 185 
Blood 24.3 9,028 21,574 887 ,399 
Placenta 
1 3.7 1'840 4,349 1 '176 ,530 
2 6.0 2,609 6' 192 1 ,032 .465 
3 3.6 1 '591 3,752 1 ,042 .469 
1l 7,3 3,404 8,097 1'109 .499 
5 6.2 3' 182 7,565 1 ,220 .549 
6 7,3 2,926 6,952 952 .429 
Fetal 
Tongue 0.3 54 69 232 . 104 
Jaws 4.5 1 ,004 2,346 521 .235 
Brain 5,5 1,012 2,365 430 . 194 
Liver & Heart 2. 1 618 1 ,42 1 677 . 305 
R. Remainder 6.3 1'279 3,005 477 .215 
L. Remainder 4.3 708 1 ,637 380 . 171 
TABLE 2(m) 
MOUSE ;113 
EFFICIENCY - 41. 73%, BACKGROUND - 25 COUNTS PER MINUTE 
LOADING DOSE+ 50 UC 
Maternal 
---
Net Wt. Raw Counts Decays Per Decays Per 
X 103 /mg (mg) Per Minute Minute/Sample Minute/mg UC 
Tongue 45.3 12,573 30,069 664 .299 
Spleen 38.7 12,816 30,652 792 .356 
Palate 2.7 807 1'874 694 . 312 
Liver 40.3 87,039 208,516 4' 174 2.33 
Total Liver 433. 1 
Brain 116. 2 5, 754 13,729 11 8 .053 
Kidney 95. 1 131,818 315,823 3,321 1. 496 
Heart 29.3 8,606 20,563 702 .316 
Adrenal 3. 1 880 2,048 661 .298 
Blood 20.6 13,053 31,219 1 '515 .683 
Placenta 
1 6.8 3,545 8 ,4 35 1 ,240 .558 
2 3.3 1 ,599 3 '772 1 '14 3 .515 
3 7. 1 6' 146 14,668 2,066 .931 
4 4.6 2 ,877 6 '834 1 ,486 .670 
5 4.7 3,001 7' 132 1 '51 7 .683 
6 5.8 4,434 10,565 1'822 . 821 
Fe ta 1 
Tongue 0.4 119 225 563 .254 
Jaws 6.7 2 '105 4,984 744 .335 
Brain 5.2 1 '714 4,047 778 . 351 
Liver & Heart 2.6 855 1 ,989 765 .345 
R. Remainder 7.7 2,424 5,749 746 .336 
L. Remainder 6.5 1 ,936 4 ,579 705 .317 
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